Related Experiment Video
Updated: Dec 3, 2025

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Correlation Between Psoriasis Severity and Nonalcoholic Fatty Liver Disease Degree Measured Using Controlled
Nico Gandha1, Larisa Paramitha Wibawa1, Tjut Nurul Alam Jacoeb1
1Department of Dermatology and Venereology, Faculty of Medicine Universitas Indonesia/Cipto Mangunkusumo Hospital, Jakarta 10430, Indonesia.
Psoriasis severity, measured by body surface area (BSA), correlates with nonalcoholic fatty liver disease (NAFLD) progression. This study highlights a link between skin disease extent and liver condition, suggesting further research into therapeutic effects.
Area of Science:
- Dermatology and Hepatology
- Metabolic Syndrome Research
Background:
- Psoriasis is increasingly linked to metabolic disorders.
- The relationship between psoriasis and nonalcoholic fatty liver disease (NAFLD) requires further investigation.
Purpose of the Study:
- To determine the correlation between psoriasis severity and the degree of NAFLD.
- To assess the relationship between psoriasis extent and liver steatosis.
Main Methods:
- Cross-sectional study of adult psoriasis patients.
- Psoriasis severity assessed using Psoriasis Area and Severity Index (PASI) and Body Surface Area (BSA).
- NAFLD degree measured by Controlled Attenuation Parameter (CAP); correlated with PASI and BSA.
Main Results:
- 77.8% of psoriasis patients had NAFLD.
- No significant correlation found between PASI and NAFLD (CAP score).
- Significant correlation observed between psoriasis Body Surface Area (BSA) and NAFLD (CAP score), as well as with BMI and abdominal circumference.
Conclusions:
- Psoriasis extension, indicated by BSA, correlates with NAFLD severity.
- Further research is needed to explore the impact of psoriasis therapies on the NAFLD link.
Related Concept Videos
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

